RxDoctor Payments Data

David Kirsch

Radiation Oncology · Durham, NCNPI 1932181039

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,304 of the $1,397 with a category attached, or 93.4%. Boehringer Ingelheim accounts for 93.4% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $1,304 and has fallen 96.8% since, to $41 in 2023.

$1,397in general payments, 2019–2025

Across 4 payments — averaging $349.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$1K
  • Siemens Medical Solutions USA, Inc.$51
  • Trisalus Life Sciences, Inc.$41
$6,169,039in research payments, 2019–2025

Across 51 payments — averaging $120,962 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$6.1M
  • Siemens Medical Solutions USA, Inc.$50K
  • Varian Medical Systems, Inc.$25K
  • Amgen$15K

What the payments were for

  • Travel & lodging$1,30493%
  • Food & beverage$937%

General payments by program year

19
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,397 in reported general payments places this provider in the 70th percentile of 199 radiation oncology providers in North Carolina.

See all radiation oncology providers in North Carolina

Other radiation oncology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →